| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $416.0M | +6.3% | +29.2% |
| Cost of Revenue | $97.0M | +7.1% | +27.5% |
| Gross Profit | $319.0M | +6.0% | +29.7% |
| R&D Expense | $86.2M | +0.7% | +12.0% |
| SG&A Expense | $66.1M | -2.6% | +5.5% |
| Operating Income | -$1.7M | +93.5% | +96.4% |
| Pre-tax Income | $9.1M | +159.9% | +124.4% |
| Income Tax | $1.3M | -17.3% | +169.6% |
| Net Income | $7.8M | +146.2% | +120.5% |
| EPS (Basic) | $0.01 | +133.3% | +114.3% |
| EPS (Diluted) | $0.01 | +133.3% | +114.3% |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $275.1M | +6.4% | +71.6% |
| Accounts Receivable | $256.7M | +4.3% | +43.6% |
| Inventory | $55.0M | +15.5% | +39.6% |
| Current Assets | $1.26B | +6.1% | +21.0% |
| Total Assets | $2.31B | +4.8% | +24.1% |
| Current Liabilities | $806.4M |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $166.5M | — | — |
| Capital Expenditures | $20.7M | — | — |
| Investing Cash Flow | -$134.7M | — | — |
| Financing Cash Flow | $17.9M | — | — |
| Free Cash Flow | $145.7M | — | — |
| +23.3% |
| Total Liabilities | $1.01B | +1.8% | +16.8% |
| Stockholders' Equity | $1.30B | +7.3% | +30.4% |